Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth hormone--from molecule to mortality.

Michael C Sheppard1

  • 1University of Birmingham. M.C.Sheppard@bham.ac.uk

Clinical Medicine (London, England)
|November 13, 2004
PubMed
Summary

Optimal levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) are crucial for health. Treatment for conditions like acromegaly and GH deficiency can improve outcomes and potentially reduce mortality risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk.

The Journal of clinical endocrinology and metabolism·2013
Same author

Medical therapy in acromegaly.

Nature reviews. Endocrinology·2011
Same author

Mortality in patients with pituitary disease.

Endocrine reviews·2010
Same author

Does acromegaly enhance mortality?

Reviews in endocrine & metabolic disorders·2007
Same author

Growth hormone assay standardization: an important clinical advance.

Clinical endocrinology·2007
Same author

Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study.

Journal of the American College of Cardiology·2007

Area of Science:

  • Endocrinology
  • Metabolic Disorders

Background:

  • Growth hormone (GH) primarily influences health through insulin-like growth factor-I (IGF-I) expression.
  • Acromegaly and hypopituitarism are linked to increased mortality, highlighting the importance of GH regulation.
  • Elevated IGF levels in taller individuals correlate with increased cancer risk, suggesting a delicate balance is necessary.

Purpose of the Study:

  • To review the role of GH and IGF-I in health and disease.
  • To discuss the impact of GH dysregulation on mortality and morbidity.
  • To explore therapeutic strategies for managing GH-related conditions.

Main Methods:

  • Literature review of studies on growth hormone and insulin-like growth factor-I.
  • Analysis of treatment outcomes for acromegaly and adult GH deficiency.
  • Examination of the relationship between height, IGFs, and cancer risk.

Main Results:

  • Somatostatin analogues and pegvisomant show efficacy in managing acromegaly, normalizing IGF-I levels in most patients.
  • GH replacement in adults offers clinical benefits but lacks data on mortality reduction.
  • A potential link exists between higher IGF levels and increased cancer risk.

Conclusions:

  • Maintaining optimal circulating GH and IGF-I levels is essential for overall health.
  • Effective treatments exist for GH-related disorders, impacting body composition, metabolic status, and quality of life.
  • Further research is needed to clarify the long-term effects of GH replacement on mortality and cancer risk.

Related Experiment Videos